1. Home
  2. MRNA vs CPB Comparison

MRNA vs CPB Comparison

Compare MRNA & CPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moderna Inc.

MRNA

Moderna Inc.

HOLD

Current Price

$40.11

Market Cap

11.5B

Sector

Health Care

ML Signal

HOLD

Logo Campbell Soup Company

CPB

Campbell Soup Company

HOLD

Current Price

$29.03

Market Cap

9.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRNA
CPB
Founded
2010
1869
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
11.5B
9.4B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
MRNA
CPB
Price
$40.11
$29.03
Analyst Decision
Hold
Hold
Analyst Count
12
16
Target Price
$31.09
$32.25
AVG Volume (30 Days)
13.7M
7.0M
Earning Date
02-13-2026
03-04-2026
Dividend Yield
N/A
5.32%
EPS Growth
N/A
5.83
EPS
N/A
1.94
Revenue
$2,232,000,000.00
$10,158,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.38
$0.97
P/E Ratio
N/A
$15.12
Revenue Growth
N/A
2.71
52 Week Low
$22.28
$25.62
52 Week High
$55.20
$43.85

Technical Indicators

Market Signals
Indicator
MRNA
CPB
Relative Strength Index (RSI) 46.93 61.84
Support Level $36.66 $28.27
Resistance Level $45.50 $29.44
Average True Range (ATR) 3.09 0.77
MACD -1.07 0.28
Stochastic Oscillator 19.45 86.94

Price Performance

Historical Comparison
MRNA
CPB

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About CPB Campbell Soup Company

Over the past 150-plus years, Campbell's has evolved into a leading domestic packaged food manufacturer, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2025 (July year-end), snacks accounted for 43% of its revenue, followed by soup (27%), other simple meals (23%), and beverages (7%). Outside its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and recently acquired Rao's (a deal that closed in 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.

Share on Social Networks: